| Michael Paul Fichter Jr, PA-C | |
|
321 Richland West Cir, Waco, TX 76712-7919 | |
| (254) 235-9355 | |
| (254) 235-0904 |
| Full Name | Michael Paul Fichter Jr |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 17 Years |
| Location | 321 Richland West Cir, Waco, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215116652 | NPI | - | NPPES |
| 284115704 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA05778 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Health Center | Waco, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| J Phillip Myatt Md Pllc | 6305089749 | 9 |
| Providence Health Alliance | 6305731068 | 129 |
| Falls Community Hospital And Clinic | 8527959816 | 14 |
News Archive
Drinking just one energy drink may have a detrimental effect on blood vessel function, according to a study to be presented at the American Heart Association's Scientific Sessions 2018 in Chicago.
New research confirms that an innovative procedure combining MRI and ultrasound to create a 3D image of the prostate can more accurately locate suspicious areas and help diagnose whether it's prostate cancer.
Denmark has one of highest incidences of cervical cancer in the Western world. But once a person has turned 65, they are no longer automatically screened - even though older women are in fact those who have the highest mortality.
The worldwide Zika threat first emerged in 2015, infecting millions as it swept across the Americas. It struck great fear in pregnant women, as babies born with severe brain birth defects quickly overburdened hospitals and public health care systems.
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Paul Fichter Jr, PA-C 321 Richland West Cir, Waco, TX 76712-7919 Ph: (254) 235-9355 | Michael Paul Fichter Jr, PA-C 321 Richland West Cir, Waco, TX 76712-7919 Ph: (254) 235-9355 |
News Archive
Drinking just one energy drink may have a detrimental effect on blood vessel function, according to a study to be presented at the American Heart Association's Scientific Sessions 2018 in Chicago.
New research confirms that an innovative procedure combining MRI and ultrasound to create a 3D image of the prostate can more accurately locate suspicious areas and help diagnose whether it's prostate cancer.
Denmark has one of highest incidences of cervical cancer in the Western world. But once a person has turned 65, they are no longer automatically screened - even though older women are in fact those who have the highest mortality.
The worldwide Zika threat first emerged in 2015, infecting millions as it swept across the Americas. It struck great fear in pregnant women, as babies born with severe brain birth defects quickly overburdened hospitals and public health care systems.
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
› Verified 7 days ago
Tiffany Ann Rose, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 120 Hillcrest Medical Blvd Ste 200, Waco, TX 76712 Phone: 254-297-0400 | |
James Hill, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 | |
Warren L Stevens, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1135 N Loop 340, Waco, TX 76705 Phone: 254-867-1962 | |
Jamie Lynn Laird, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5400 Crosslake Pkwy Ste 300, Waco, TX 76712 Phone: 254-420-2336 Fax: 254-666-8064 | |
Mr. Richard James Hecker, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 1226 Washington Ave, Waco, TX 76701 Phone: 254-313-6300 Fax: 254-313-6349 | |
Jourdan Brown Whorley, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-313-4200 | |
Brittany Morgan Zipperlen, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5400 Crosslake Pkwy, Waco, TX 76712 Phone: 254-420-2336 |